Taken together, these results showed that inhibition of UBE2C could promote Parkin‐mediated K63‐linked ubiquitination of TOP2A to induce senescence and sensitize breast cancer cells to doxorubicin (Figure 8). The gene discussed is UBE2C; the disease is breast cancer.